Get your daily dose of Ghost Mail with all the news from the previous day on the JSE.
 

Good Morning Voornaam

We’ve reached the end of the first week of the new and improved Ghost Mail! I’ve loved every minute of it and I hope you have as well, despite markets having had an awful week.

In case you haven’t noticed, I love charts. To bring this week to a close, I decided to include a share price chart for Sibanye-Stillwater, a company that I hold in my portfolio (source: Google Finance):

You need a strong stomach for this market, that’s for sure. This is a sell-off of over 40% since the recent peak in March although there was a dividend paid in that period. This chart is exactly why I’m a fan of having a diversified portfolio with many smaller positions, rather than a concentrated portfolio with hills that I’m prepared to die on. The markets are uncertain and I avoid having any such hills!

One of the most interesting things about the market is how companies can report such different results. For example, today’s feature articles are on Sappi with
great numbers this quarter and Harmony with production challenges driving a knock to profits.

There are many more
earnings updates and other snippets of news in Ghost Bites this morning.

I worked in the corporate finance industry for six years and it was critical to me to retain the
DealMakers updates as part of the merger of Ghost Mail with InceConnect. Each Friday, we will continue to benefit from the summaries and thought leadership pieces published by DealMakers. You’ll find all of them at this link.

We are seeing significant moves in our currency and in commodity prices at the moment. Wichard Cilliers (Head of Market Risk at TreasuryONE) has summarised yesterday’s moves for us:

“The rand held its own yesterday, with the local currency closing on the front foot. After opening around R16.18, we saw weakness on the local currency up towards the R16.25 mark on the back of sustained dollar strength. We have seen an exciting move in the late afternoon with the rand back at R16.10 even with EUR/USD trading below 1.04. Other emerging markets are also grinding their way back to stronger levels with the risk-off sentiment winding down. Metals are under massive pressure with gold that is supposed to be hedge against inflation not even rallying.”

I continue to scratch my head over gold, which has not behaved itself during this period of inflation. For more details on US inflation and treasuries,
check out this article from TreasuryONE that they released yesterday morning.

Finally, have a listen to the latest free Magic Markets podcast where we welcomed Justine Brophy from AnBro Capital Investments to the show. We talked about whether growth stocks have bottomed. We also looked at three Biotech stocks that the investment specialists at AnBro are looking at. As always,
there’s much to learn here!

Have a terrific weekend and let your hair down after such a hectic week.

 

Earnings updates are a mixed bag at the moment, as some companies flourish and others falter in this environment. 

Sappi is taking advantage of favourable market conditions, posting a strong earnings performance in the second quarter.

Harmony Gold's Hidden Valley operation has taken the shine off results this year.

As part of the suite of DealMakers content today, there’s a summary of M&A activity for the first quarter of the year. 

Justine Brophy from AnBro joined us to discuss whether we’ve seen the bottom in growth stocks. We also looked at three examples of biotech stocks.

 
 

EasyEquities is a product of First World Trader (Pty) Ltd t/a EasyEquities which is an authorized financial services provider (FSP no.2225880) and a registered credit provider (NCRCP12294).

EasyProperties is a juristic representative of the First World Trader (PTY) Ltd t/a EasyEquities which is an authorised financial services provider (FSP) number 22588.

EasyEquities does not act as an FSP when allowing you to buy and sell the EC10 bundle as well as any other cryptocurrencies.

 



Disclaimer

Our content is intended to be used and must be used for informational purposes only. You must do your own analysis before executing any investments or strategic decisions, based on your own circumstances. We do not provide personalised recommendations or views as to whether an investment approach or corporate strategy is suited to the needs of a specific individual or entity. You should take independent financial advice from a suitably qualified individual who gives due regard to your personal circumstances.

Whilst every care is taken, we accept no responsibility or liability for any errors or omissions in any of our content.

The views, thoughts and opinions expressed in our content belong solely to the author or quoted individuals and/or entities, and not necessarily to the author's employer, organisation, committee or other group or individual, or any of our affiliates or brand partners.